These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9850698)

  • 41. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When an asthma drug has an inferiority complex: a noninferiority trial.
    Goodman DC
    Pediatrics; 2005 Aug; 116(2):493-5. PubMed ID: 16061609
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhaled corticosteroids or antileukotrienes for asthma?
    Hampson NB
    Ann Intern Med; 1999 Dec; 131(11):865. PubMed ID: 10610635
    [No Abstract]   [Full Text] [Related]  

  • 44. [Reflections on antileukotrienes].
    Naberan Toña KX; Martínez González A; Mendia JL
    Aten Primaria; 2002 Apr; 29(6):356-8. PubMed ID: 11996716
    [No Abstract]   [Full Text] [Related]  

  • 45. [New approaches to treatment of occupational bronchial asthma].
    Petrykina MV; Kuz'mina LP; Sorkina NS
    Med Tr Prom Ekol; 2010; (7):33-6. PubMed ID: 20853629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biased about the treatment of asthma in children].
    Wickman M; Gustafsson P
    Lakartidningen; 2007 Dec; 104(51-52):3902; author reply 3902-3. PubMed ID: 18232537
    [No Abstract]   [Full Text] [Related]  

  • 47. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Montelukast in treatment of mild and severe forms of asthma.
    Ekaladze E; Pkhakadze I; Alavidze N; Jugeli K
    Georgian Med News; 2014; (232-233):56-60. PubMed ID: 25214273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asthma biomarkers and drug trials.
    Frew AJ
    J Allergy Clin Immunol; 2002 Feb; 109(2):210-3. PubMed ID: 11842288
    [No Abstract]   [Full Text] [Related]  

  • 50. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Montelukast: a new medication for pediatric asthma management.
    Stohlmeyer LA
    J Pediatr Health Care; 1998; 12(6 Pt 1):324-8; quiz 329-30. PubMed ID: 10392110
    [No Abstract]   [Full Text] [Related]  

  • 52. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Montelukast for persistent asthma.
    Med Lett Drugs Ther; 1998 Jul; 40(1031):71-3. PubMed ID: 9698701
    [No Abstract]   [Full Text] [Related]  

  • 54. [Leukotriene and respiratory syncytial virus].
    Zhang WX; Li CC
    Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):109-10. PubMed ID: 23527973
    [No Abstract]   [Full Text] [Related]  

  • 55. The emerging role of leukotriene antagonists in asthma therapy.
    Lipworth BJ
    Chest; 1999 Feb; 115(2):313-6. PubMed ID: 10027422
    [No Abstract]   [Full Text] [Related]  

  • 56. 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
    Tantisira KG; Lima J; Sylvia J; Klanderman B; Weiss ST
    Pharmacogenet Genomics; 2009 Mar; 19(3):244-7. PubMed ID: 19214143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Leukotriene antagonists--do they have a value?].
    Stey C
    Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.
    Storms W
    Expert Opin Pharmacother; 2007 Sep; 8(13):2173-87. PubMed ID: 17714069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous montelukast in acute asthma: expensive aminophylline?
    Dempsey OJ; Lipworth BJ
    Thorax; 2000 Sep; 55(9):808-9. PubMed ID: 11012372
    [No Abstract]   [Full Text] [Related]  

  • 60. [Efficacy of montelukas in the prevention of acute asthma episode in children].
    Zhu ML; He S
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):695-6. PubMed ID: 19695205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.